SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,128,349,000 | +12.5% | 10,876,125 | -2.4% | 0.07% | +4.5% |
| Q2 2020 | $1,892,703,000 | +45.1% | 11,138,781 | -1.5% | 0.07% | +19.6% |
| Q1 2020 | $1,304,781,000 | +4.6% | 11,308,553 | +3.6% | 0.06% | +30.2% |
| Q4 2019 | $1,247,282,000 | +36.8% | 10,916,170 | +2.3% | 0.04% | +26.5% |
| Q3 2019 | $911,474,000 | +40.2% | 10,672,997 | +13.6% | 0.03% | +41.7% |
| Q2 2019 | $650,116,000 | -4.2% | 9,393,384 | +1.4% | 0.02% | -11.1% |
| Q1 2019 | $678,281,000 | +29.5% | 9,261,066 | +0.2% | 0.03% | +12.5% |
| Q4 2018 | $523,818,000 | -23.8% | 9,244,948 | +3.7% | 0.02% | -11.1% |
| Q3 2018 | $687,461,000 | +18.1% | 8,914,184 | +1.7% | 0.03% | +12.5% |
| Q2 2018 | $581,923,000 | +28.8% | 8,765,205 | +1.5% | 0.02% | +20.0% |
| Q1 2018 | $451,783,000 | +8.5% | 8,631,722 | +10.9% | 0.02% | +11.1% |
| Q4 2017 | $416,470,000 | -0.2% | 7,784,502 | +1.5% | 0.02% | -10.0% |
| Q3 2017 | $417,394,000 | +7.1% | 7,671,285 | +1.9% | 0.02% | +5.3% |
| Q2 2017 | $389,628,000 | -15.8% | 7,530,515 | +2.3% | 0.02% | -20.8% |
| Q1 2017 | $462,818,000 | +23.7% | 7,362,687 | +3.9% | 0.02% | +14.3% |
| Q4 2016 | $374,014,000 | -2.5% | 7,087,643 | -0.2% | 0.02% | -8.7% |
| Q3 2016 | $383,630,000 | +33.5% | 7,102,952 | -0.1% | 0.02% | +27.8% |
| Q2 2016 | $287,335,000 | +18.1% | 7,110,502 | +2.6% | 0.02% | +12.5% |
| Q1 2016 | $243,248,000 | -21.2% | 6,932,099 | +0.7% | 0.02% | -23.8% |
| Q4 2015 | $308,823,000 | +16.5% | 6,881,088 | +0.1% | 0.02% | +110.0% |
| Q3 2015 | $265,051,000 | -12.1% | 6,873,711 | +10.3% | 0.01% | -50.0% |
| Q2 2015 | $301,543,000 | +39.0% | 6,230,220 | +1.5% | 0.02% | +33.3% |
| Q1 2015 | $216,881,000 | +9.5% | 6,135,243 | -0.5% | 0.02% | +7.1% |
| Q4 2014 | $198,102,000 | -12.4% | 6,165,667 | +1.3% | 0.01% | -22.2% |
| Q3 2014 | $226,190,000 | -4.9% | 6,083,674 | -2.2% | 0.02% | -5.3% |
| Q2 2014 | $237,882,000 | -17.4% | 6,219,143 | -1.6% | 0.02% | -20.8% |
| Q1 2014 | $287,972,000 | +10.8% | 6,320,727 | -3.0% | 0.02% | +4.3% |
| Q4 2013 | $259,839,000 | -2.3% | 6,513,889 | +7.3% | 0.02% | -11.5% |
| Q3 2013 | $266,024,000 | +45.8% | 6,069,445 | +4.6% | 0.03% | +36.8% |
| Q2 2013 | $182,492,000 | – | 5,800,799 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |